Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

24 déc. 2025 06h00 HE | Source: Equity Insider

Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge

VANCOUVER, British Columbia, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Equity Insider News Commentary – The U.S. oncology market is projected to surge from $81 billion in 2025 to $212 billion by 2034[1],...
11 déc. 2025 09h14 HE | Source: Equity Insider

THE REALITY CHECK: 5 Assets Delivering Proof in a Speculative Market

Issued on behalf of Quantum Security Encryption Corp. VANCOUVER, British Columbia, Dec. 11, 2025 (GLOBE NEWSWIRE) -- EquityInsider.com Market Intelligence Brief The capital rotation is underway....
26 mars 2024 17h00 HE | Source: GT Biopharma, Inc.

GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results

Remain in active dialogue with the FDA regarding IND clearance for GTB-3650, a 2nd generation nanobody TriKE® for treatment of CD33+ leukemiaPhase 1 trial with GTB-3650 anticipated to start in 2H...